10-KThe Record
Taysha Gene Therapies, Inc. files 10-K
Filed Mar 31, 2022 · 4y ago · Accession 0001564590-22-012782
Plain English
Annual report — full-year financials, business overview, and risk factors.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- 10-K
- Filing date
- Mar 31, 2022
- Report date
- Dec 31, 2021
- Document
- tsha-10k_20211231.htm
- Size
- 34.5 MB